{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T05:54:37Z","timestamp":1663739677853},"reference-count":18,"publisher":"Georg Thieme Verlag KG","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1055\/a-1767-8281","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T23:25:03Z","timestamp":1663716303000},"page":"1243-1250","source":"Crossref","is-referenced-by-count":0,"title":["Autoimmunh\u00e4molytische An\u00e4mien"],"prefix":"10.1055","volume":"147","author":[{"given":"Sabine","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Wichmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"Spiekermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,9,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3324\/haematol.2013.091702","article-title":"Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma","volume":"99","author":"U Randen","year":"2014","journal-title":"Haematologica"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4103\/ajts.AJTS_105_17","article-title":"Immunohematological and clinical characterizations of mixed autoimmune hemolytic anemia","volume":"12","author":"S S Das","year":"2018","journal-title":"Asian J Transfus Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"100648","DOI":"10.1016\/j.blre.2019.100648","article-title":"Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting","volume":"41","author":"U J\u00e4ger","year":"2020","journal-title":"Blood Reviews"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/ajh.2830440404","article-title":"Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients","volume":"44","author":"G Flores","year":"1993","journal-title":"Am J Hematol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/MOH.0b013e3282c8ca66","article-title":"Evidence based therapeutic apheresis in autoimmune and other hemolytic anemias","volume":"14","author":"B C McLeod","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1182\/blood.2019003808","article-title":"How I treat warm autoimmune hemolytic anemia","volume":"137","author":"W Barcellini","year":"2021","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/bjh.12541","article-title":"A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia","volume":"163","author":"H Birgens","year":"2013","journal-title":"Br J Haematol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/ajh.24570","article-title":"A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study)","volume":"92","author":"M Michel","year":"2017","journal-title":"Am J Hematol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMra2033982","article-title":"Autoimmune Hemolytic Anemias","volume":"385","author":"S Berentsen","year":"2021","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1182\/asheducation-2018.1.382","article-title":"Autoimmune hemolytic anemia","volume":"2018","author":"A Hill","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jtcvs.2013.03.009","article-title":"Cold agglutinins in patients undergoing cardiac surgery requiring cardiopulmonary bypass","volume":"146","author":"D W Barbara","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/bjh.14478","article-title":"The diagnosis and management of primary autoimmune haemolytic anaemia","volume":"176","author":"Q A Hill","year":"2017","journal-title":"Br J Haematol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1182\/blood.2020005674","article-title":"Cold agglutinin disease revisited: a multinational, observational study of 232 patients","volume":"136","author":"S Berentsen","year":"2020","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1182\/blood-2010-06-288647","article-title":"High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease","volume":"116","author":"S Berentsen","year":"2010","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1182\/blood-2017-04-778175","article-title":"Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial","volume":"130","author":"S Berentsen","year":"2017","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1182\/blood.2021012039","article-title":"Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease\/cold agglutinin syndrome","volume":"138","author":"M Jalink","year":"2021","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1182\/blood-2018-03-835413","article-title":"Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study","volume":"132","author":"G Rossi","year":"2018","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1056\/NEJMoa2027760","article-title":"Sutimlimab in Cold Agglutinin Disease","volume":"384","author":"A R\u00f6th","year":"2021","journal-title":"N Engl J Med"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1767-8281.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T23:25:46Z","timestamp":1663716346000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1767-8281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":18,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2022,9,20]]},"published-print":{"date-parts":[[2022,9]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1767-8281","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}